Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital & Trauma Care Services Ltd share price inched up 1.16% to Rs 938.85 after the company's net profit saw a marginal increase of 6.69% to Rs 48.46 crore, while revenue from operations improved marginally 9.87% to Rs 431.42 crore in Q3FY26 over Q2FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 6.74 lakh crore, easing 7.93%. It has marginally improved by 5.08% over last one week and dropped by 9.59% in last one month while the market capitalization of Yatharth Hospital & Trauma Care Services Ltd has slipped by 1.45% and 9.58% in the same period respectively. Profit before tax (PBT) of Yatharth Hospital & Trauma Care Services Ltd stood at Rs 65.61 crore in Q3 FY26, rallying 19.68% year-on-year, and rising 7.19% quarter-on-quarter. EBITDA came in at Rs 97 crore, expanding by 76.27% YoY and rising by 11.07% sequentially. Total expenses increased by 10.13% to Rs 362.55 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 78.17 crore, growing marginally by 9.94% YoY, while employee benefits expense was at Rs 84.34 crore, improving by 8.25% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 37.10% to Rs 1207.17 crore, while net profit soared by 30.46% to Rs 170.31 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 23371% to Rs 266.33 crore, and PBT soared 30.17% to Rs 223.56 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 204.52 crore in FY26, as against Rs 131.17 crore in FY25. Yatharth Hospital & Trauma Care Services Ltd jumped 15.31% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 9.87% during the same period.

Yatharth Hospital & Trauma Care Services Limited will hold a board meeting on Tuesday, November 03, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the second quarter and half year ended September 30, 2026, along with a limited review report, the company said in a filing. The trading window for designated persons and their immediate relatives has been closed since October 1, 2026, and will remain closed until 48 hours after the results are made public.

Yatharth Hospital & Trauma Care Services Limited convened an Extra-Ordinary General Meeting (EGM) on Thursday, October 15, 2026, where members approved a strategic investment by Rasmalai Limited, an affiliate of Advent International, through a preferential issue of equity shares and warrants. Mr. Yatharth Tyagi, Whole-time Director, welcomed members and highlighted the investment’s potential to accelerate growth, strengthen the company’s financial position, and create long-term value for shareholders, with the proceeds to be utilized for growth and governance-related matters. The resolutions included increasing the authorized share capital, issuing subscription securities, adopting amended articles of association, and approving an upside share arrangement.

Yatharth Hospital & Trauma Care Services Limited informed the National Stock Exchange of India Limited and BSE Limited that it has received a certificate dated October 3, 2026, from MUFG Intime India Private Limited, its Registrar and Share Transfer Agent, confirming the processing of securities for dematerialization for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Yatharth Hospitals & Trauma Care Ltd. has released a corrigendum to the notice for its Extraordinary General Meeting (EGM), primarily to ensure compliance with Securities and Exchange Board of India (SEBI) regulations and the Foreign Exchange Management Act (FEMA). The preferential allotment of shares and warrants is confirmed at INR 985.17, with valuation reports from Abhinav Agarwal and RS Grover and Associates now publicly accessible. The corrigendum clarifies the pricing methodology and outlines interim investment options for unutilized proceeds, including money market instruments and deposits. CRISIL Ratings Limited has been appointed as a Monitoring Agency to oversee fund utilization, with quarterly reports to be published. Shareholders will vote on the preferential allotment at the EGM.

Yatharth Hospital & Trauma Care Services Limited informed the National Stock Exchange of India Limited and BSE Limited that the trading window for dealing in the company’s securities will be closed for designated persons and their immediate relatives from October 1, 2026, and will reopen 48 hours after the declaration of the un-audited financial results for the second quarter and half year ending September 30, 2026.

Promoters retain significant control over the company through provisions outlined in recently released articles, granting them the right to nominate directors and influence key strategic decisions. The Promoters can nominate a majority of non-independent directors if they collectively own at least 10% of the company’s equity on a fully diluted basis, or two directors with at least 5% ownership. Reserved Matters, including debt issuance, mergers and acquisitions, and asset sales, require Promoter approval. However, these special rights diminish as the Promoters’ ownership stake falls below 5%, with no possibility of revival. After four years and six months, shareholder approval will be required to renew these special rights, and the Promoters and Investor must cooperate to secure that approval.

Yatharth Hospital & Trauma Care Services Limited is set to receive a significant investment from Rasmalai Limited through a preferential issue of 1,30,26,516 equity shares and 1,89,47,664 warrants. The deal, finalized September 17, 2026, will result in Rasmalai Limited holding approximately 24.87% of the company’s fully diluted share capital and becoming a public, non-promoter shareholder. As part of the agreement, Rasmalai Limited will have the right to nominate directors to the board and key committees, alongside existing promoter rights. The promoters, including Dr. Ajay Kumar Tyagi, Dr. Kapil Kumar, Dr. Neena Tyagi, and Dr. Manju Tyagi, are subject to a three-year lock-in period and could potentially transfer shares to Dr. Tyagi if Rasmalai Limited achieves a three-times return on its investment. The transaction remains contingent on approvals from regulatory bodies including the BSE Limited and National Stock Exchange of India Limited.

Yatharth Hospital & Trauma Care Services Limited has entered into an agreement with Rasmalai Limited, a Cyprus-based investor, for a preferential issue of securities valued at approximately INR 31.5 billion. The transaction will grant Rasmalai Limited a 24.87% stake in the company on a fully diluted basis. As part of the agreement, Rasmalai Limited will have the right to nominate directors to the board and approve certain key decisions, contingent on shareholding thresholds. Existing promoters, including Dr. Ajay Kumar Tyagi, Dr. Kapil Kumar, Dr. Neena Tyagi, and Dr. Manju Tyagi, will also retain certain rights and are subject to a three-year lock-in period on their shares. The deal, finalized September 17, 2026, requires regulatory approvals from the BSE Limited, National Stock Exchange of India Limited, and the Competition Commission of India and does not constitute a change in control of the company.

Yatharth Hospital & Trauma Care Services Limited will hold a board meeting on Thursday, September 17, 2026, to discuss growth plans and consider raising funds through debt, a rights issue, preferential allotment, qualified institutions placement, or other permissible modes, potentially including equity shares, warrants, debt securities, or other eligible securities.